AVTX
Avalo Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AVTX fundamentals
Avalo Therapeutics (AVTX) released its earnings on Aug 7, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -1.92 (YoY -145.61%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-1.92
-145.61%
Report date
Aug 7, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Avalo Therapeutics (AVTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Avalo Therapeutics (AVTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Avalo Therapeutics (AVTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Avalo Therapeutics (AVTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Avalo Therapeutics (AVTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Avalo Therapeutics (AVTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Avalo Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Avalo Therapeutics next quarter?What is the revenue and EPS growth rate for Avalo Therapeutics year over year?What is Avalo Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Avalo Therapeutics's earnings call?What were the key takeaways from Avalo Therapeutics’s earnings call?What factors drove the changes in Avalo Therapeutics's revenue and profit?What guidance did Avalo Therapeutics's management provide for the next earnings period?
